• FOLLOW US
Video Player
  • Email
  • share

AstraZeneca Spurns Pfizer Bid, Earnings News & a Jim Cramer Pick

Pfizer sweetened its bid to buy out British pharma company Astrazeneca--a move that would also shift the tax base of the American company overseas--but its target spurned its $106 billion bid. LinkedIn is among loss leaders on the tech scene in 2014,

http://www.11alive.com/video/3530348592001/1/AstraZeneca-Spurns-Pfizer-Bid-Earnings-News--a-Jim-Cramer-Pick http://cdn.newslook.com/59/599d92b61f28d1a5f40806c2770c8b81/images/frame_ext.jpg AstraZeneca Spurns Pfizer Bid, Earnings News & a Jim Cramer Pick Pfizer sweetened its bid to buy out British pharma company Astrazeneca--a move that would also shift the tax base of the American company overseas--but its target spurned its $106 billion bid. LinkedIn is among loss leaders on the tech scene in 2014, jim cramerFinancelinkedinAZNyoutubeYahoo!newslookastrazeneca plc 02:02

Next Up

    

More Videos